Quantcast

Posts related to ‘ArQule’

biotech

ArQule Fails in Colorectal Cancer Trials

Posted: January 11, 2013 at 9:09 am

ArQule Inc. (NASDAQ: ARQL) is about to lose some serious hope for investors. It and Daiichi Sankyo announced that the top-line results of phase 2 trial with tivantinib in colorectal cancer did not meet ...
Read Full Story »

Today’s Market Winners and Losers

Posted: October 2, 2012 at 10:48 am

The stock market is mixed on Tuesday, with the Dow Jones Industrial Average down 0.01%, the Nasdaq up 0.21% and the S&P up 0.51%. Tuesday's winners include a telecommunications company ...
Read Full Story »